Ugorcáková J, Hlavatý T, Babál P, Janega P, Bukovská G, Halgasová N, Hlavatá A, Timko J, Duris I
Institute of Molecular Biology, Slovak Academy of Sciences, 84551 Bratislava, Slovak Republic.
Neoplasma. 2006;53(5):363-71.
The aim of our work was to develop a fast, reliable and sensitive PCR method to detect K-ras mutations in various clinical samples. There is a need for an unimpeachable method for early diagnosis and/or screening of pancreatic cancer (PC). We optimized and subsequently analyzed four methods based on mutant-enriched PCR for the sensitivity, cost and time expense. Using the selected optimal method we examined codon 12 K- ras mutations in a study population of 59 patients with upper GIT malignancies. Reliability of the genotyping was confirmed by sequencing. By using the best of our modified mutant-enriched PCR methods we achieved sensitivity of 1:1 x 10(5). Further studies are necessary to determine the optimal biological material sampling in PC.
我们工作的目的是开发一种快速、可靠且灵敏的PCR方法,以检测各种临床样本中的K-ras突变。对于胰腺癌(PC)的早期诊断和/或筛查,需要一种无懈可击的方法。我们基于突变富集PCR对四种方法进行了优化并随后分析了其灵敏度、成本和时间消耗。使用选定的最佳方法,我们在59例上消化道恶性肿瘤患者的研究群体中检测了密码子12的K-ras突变。通过测序确认了基因分型的可靠性。通过使用我们改良的最佳突变富集PCR方法,我们实现了1:1×10(5)的灵敏度。有必要进行进一步研究以确定PC中最佳的生物材料采样方法。